ICARES Medicus, Inc. (TPEX:6612)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
69.20
+1.20 (1.76%)
Mar 5, 2026, 12:54 PM CST
-37.09%
Market Cap 3.22B
Revenue (ttm) 1.09B
Net Income (ttm) 63.38M
Shares Out 47.38M
EPS (ttm) 1.34
PE Ratio 50.66
Forward PE n/a
Dividend 0.27 (0.39%)
Ex-Dividend Date Aug 22, 2025
Volume 18,119
Average Volume 63,740
Open 69.00
Previous Close 68.00
Day's Range 68.80 - 69.80
52-Week Range 66.30 - 123.64
Beta 0.44
RSI 34.61
Earnings Date Mar 12, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyperopia, presbyopia, or astigmatism. In addition, it offers lubricious coatings and various surface treatments for implantable or interventional medical d... [Read more]

Sector Healthcare
Founded 2011
Employees 77
Stock Exchange Taipei Exchange
Ticker Symbol 6612
Full Company Profile

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.

Financial Statements

News

There is no news available yet.